Andrew Kalusa

779 total citations
6 papers, 121 citations indexed

About

Andrew Kalusa is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Andrew Kalusa has authored 6 papers receiving a total of 121 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Organic Chemistry and 1 paper in Oncology. Recurrent topics in Andrew Kalusa's work include Click Chemistry and Applications (1 paper), RNA modifications and cancer (1 paper) and Synthesis and biological activity (1 paper). Andrew Kalusa is often cited by papers focused on Click Chemistry and Applications (1 paper), RNA modifications and cancer (1 paper) and Synthesis and biological activity (1 paper). Andrew Kalusa collaborates with scholars based in United Kingdom. Andrew Kalusa's co-authors include Keith Jones, N. Chessum, Maciej Kaliszczak, Eric O. Aboagye, Laurence Carroll, Sebastian Trousil, Paul Workman, Craig McAndrew, Martin Rowlands and Chrisostomos Prodromou and has published in prestigious journals such as Tetrahedron Letters, Oncotarget and Bioorganic & Medicinal Chemistry Letters.

In The Last Decade

Andrew Kalusa

6 papers receiving 120 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andrew Kalusa United Kingdom	5	82	38	22	14	11	6	121
Niklas Uhlenbrock Germany	6	127 1.5×	45 1.2×	10 0.5×	17 1.2×	20 1.8×	6	164
Elena Ho United States	9	122 1.5×	57 1.5×	12 0.5×	33 2.4×	30 2.7×	15	270
Neil Garton United Kingdom	7	119 1.5×	102 2.7×	14 0.6×	19 1.4×	14 1.3×	12	231
Shuqun Lin United States	8	76 0.9×	95 2.5×	9 0.4×	26 1.9×	25 2.3×	9	195
Annika Jenmalm Jensen Sweden	8	90 1.1×	41 1.1×	8 0.4×	13 0.9×	28 2.5×	13	144
C. Hamlett United Kingdom	4	123 1.5×	67 1.8×	6 0.3×	28 2.0×	15 1.4×	5	188
Jin-Xiong She China	6	49 0.6×	29 0.8×	10 0.5×	9 0.6×	12 1.1×	12	125
Yann‐Vaï Le Bihan United Kingdom	10	244 3.0×	44 1.2×	12 0.5×	20 1.4×	22 2.0×	17	281
Sara N. Journey United States	5	95 1.2×	23 0.6×	4 0.2×	13 0.9×	24 2.2×	5	147
Shuangying Liu China	9	108 1.3×	49 1.3×	20 0.9×	11 0.8×	25 2.3×	19	207

Countries citing papers authored by Andrew Kalusa

Since Specialization

Citations

This map shows the geographic impact of Andrew Kalusa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Kalusa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Kalusa more than expected).

Fields of papers citing papers by Andrew Kalusa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Kalusa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Kalusa. The network helps show where Andrew Kalusa may publish in the future.

Co-authorship network of co-authors of Andrew Kalusa

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Kalusa. A scholar is included among the top collaborators of Andrew Kalusa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Kalusa. Andrew Kalusa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Trousil, Sebastian, Maciej Kaliszczak, Zachary T. Schug, et al.. (2016). The novel choline kinase inhibitor ICL-CCIC-0019 reprograms cellular metabolism and inhibits cancer cell growth. Oncotarget. 7(24). 37103–37120. 31 indexed citations

2.

Cheeseman, Matthew D., Amir Faisal, Sydonia Rayter, et al.. (2014). Targeting the PPM1D phenotype; 2,4-bisarylthiazoles cause highly selective apoptosis in PPM1D amplified cell-lines. Bioorganic & Medicinal Chemistry Letters. 24(15). 3469–3474. 4 indexed citations

3.

Couty, S., Isaac M. Westwood, Andrew Kalusa, et al.. (2013). The discovery of potent ribosomal S6 kinase inhibitors by high-throughput screening and structure-guided drug design. Oncotarget. 4(10). 1647–1661. 17 indexed citations

4.

Trousil, Sebastian, Laurence Carroll, Andrew Kalusa, et al.. (2013). Design of symmetrical and nonsymmetrical N,N-dimethylaminopyridine derivatives as highly potent choline kinase alpha inhibitors. MedChemComm. 4(4). 693–693. 17 indexed citations

5.

Rowlands, Martin, Craig McAndrew, Chrisostomos Prodromou, et al.. (2010). Detection of the ATPase Activity of the Molecular Chaperones Hsp90 and Hsp72 Using the Transcreener™ ADP Assay Kit. SLAS DISCOVERY. 15(3). 279–286. 27 indexed citations

6.

Kalusa, Andrew, N. Chessum, & Keith Jones. (2008). An efficient synthesis of 2,3-diaryl (3H)-quinazolin-4-ones via imidoyl chlorides. Tetrahedron Letters. 49(41). 5840–5842. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact